glp-1 and kidney Repurposing Diabetes Therapies in CKD: Mechanistic Insights, Clinical Outcomes Safety of SGLT2i and RAs glp-1 kidney outcomes news Association

Semaglutide among Type 2 diabetes patients had the target dose of 1.0 mg granted permission by FDA in 2017 and EMA in 2018

Lean protein at about 30 grams should be sufficient (the 20-40g range is fine)

Infused with Glutathione , a master antioxidant, along with Vitamin C and Niacinamide , it helps reduce pigmentation, fade dark spots, and protect against free radical damage

Transient and mostly mild-to-moderate gastrointestinal symptoms were the most frequently reported AE and occurred more frequently with the 4 mg starting dose groups rather than the 2 mg starting dose groups [67]

For more insights on optimizing your health and understanding your body's signals, check out the full video on the Health Made Clear YouTube channel